BDDONCT07915986
Brain Dopamine Dynamics in Obesity
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Dopamine (DA) release
Timeframe: Visit 4, approximately week 4. Baseline D2/3R binding potential will be assessed at T=30'. PET time-activity curves are then measured continuously for 60 minutes from milkshake onset.
Time to onset of DA peaks
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Duration of DA peaks
Timeframe: Visit 4, approximately week 4.PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Time to onset of DA peaks between men and women
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Duration of DA peaks between men and women
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Magnitude of DA release between men and women
Timeframe: Visit 4, approximately week 4. PET time-activity curves are measured continuously for 60 minutes from milkshake onset (30-90 minutes after initiation of radiotracer administration).
Secondary (11)
Glucose
Insulin
FFA
Gut peptides (tbd)
Yale Food Addiction Scale 2.0 score
Show 6 moreShow less
Barratt Impulsiveness Scale (BIS-11) score
Dietary Fat and Free Sugar - Short Questionnaire (DFS)
Change in Delay Discounting Task
Change in Iowa Gambling Task score
Behavioral Inhibition System/Behavioral Activation System Scale score
Change in Visual Analogue Scale (VAS) score
Arms and interventions
Adults with obesityExperimental
Four visits per participant: screening, PET practice session, MRI+behavioral assessment, milkshake+PET scan.
Adults with normal weightExperimental
Four visits per participant: screening, PET practice session, MRI+behavioral assessment, milkshake+PET scan.
Other: Milkshake
Devices: NeuroEXPLORER
Drugs: [11C]raclopride
Sites
1 site in 1 country
- Yale School of MedicineNew Haven, Connecticut, United States